IRWD - Ironwood Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.01 revenue of $104.06M beats by $3.46M
2023-05-04 07:16:41 ET
- Ironwood Pharmaceuticals press release ( NASDAQ: IRWD ): Q1 Non-GAAP EPS of $0.25 beats by $0.01 .
- Revenue of $104.06M (+6.7% Y/Y) beats by $3.46M .
- 2023 Guidance: U.S. LINZESS Net Sales Growth 3% to 5%, Total Revenue $420 to $435 million, Adjusted EBITDA >$250 million.
For further details see:
Ironwood Pharmaceuticals Non-GAAP EPS of $0.25 beats by $0.01, revenue of $104.06M beats by $3.46M